Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions

Conditions

Catheter Ablation, Coronary Angiography, Electrophysiologic Testing (EP), Internal Cardioverter Defibrillator (ICD), Percutaneous Coronary Intervention (PCI), Sudden Cardiac Death, Ventricular Fibrillation, Ventricular Tachycardia

Brief summary

The Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions (RACE-IT) represents a mono-centric registry of patients being hospitalized suffering from malignant arrythmias (ventricular tachycardia or fibrillation) and sudden cardiac death (SCD). Detailed findings of patients' clinical outcome regarding mortality and co-morbidities related to the presence of invasive diagnostics or therapies including coronary angiography, percutaneous coronary intervention (PCI), electrophysiological testing (EP), catheter ablation and implanted cardiac devices (e.g. implantable cardioverter-defibrillators) will be documented. Patients will be included when being hospitalized from the year 2004 until today.

Weidner K, Behnes M, Schupp T, Hoppner J, El-Battrawy I, Ansari U, Saleh A, Taton G, Reiser L, Bollow A, Reichelt T, Ellguth D, Engelke N, Bertsch T, Große Meininghaus D, Hoffmann U, Akin I.

2022-03-31

10.1186/s12872-022-02552-6

Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias.

Rusnak J, Behnes M, Schupp T, Lang S, Reiser L, Taton G, Bollow A, Reichelt T, Ellguth D, Engelke N, Ansari U, El-Battrawy I, Bertsch T, Nienaber CA, Akin M, Mashayekhi K, Weiß C, Borggrefe M, Akin I.

2019-05-249 citations

10.1186/s12944-019-1011-x

Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia.

Schupp T, Behnes M, Weiß C, Nienaber C, Lang S, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, Ansari U, El-Battrawy I, Bertsch T, Akin M, Mashayekhi K, Borggrefe M, Akin I.

2018-08-0116 citations

10.1007/s10557-018-6812-z

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

Hospitalization due to: * ventricular tachycardia * ventricular fibrillation * sudden cardiac death

Exclusion criteria

* not diagnosed with one or more of the above

Design outcomes

Primary

Measure	Time frame
Incidence of ventricular arrythmias (i.e. ventricular fibrillation, ventricular tachykardia, asystole, SCD)	Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime

Secondary

Measure	Time frame
Incidence of coronary artery disease (CAD) and PCI in patients with VF/VT/SCD	Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime
Incidence of invasive electrophysiologic testing (EP) and catheter ablation	Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime
Incidence of treatment with cardiac devices (i.e. ICD, CCM, CRT-D)	Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime
Incidences of recurrent malignant tachycardias, all-cause mortality, arrhythmia-related death, re-PCI/ACVB, re-ablation, further therapy with cardiac devices	Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime

Countries

Germany

Contacts

Primary ContactIbrahim Akin, Prof. Dr.

ibrahim.akin@umm.de+49 621 383 5229

Backup ContactMichael Behnes, Dr. med.

michael.behnes@umm.de+49 621 383 6239

Outcome results